- Home
- NBIX vs APG Comparison
NBIX vs APG Comparison
Compare NBIX & APG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NBIX
- APG
- Stock Information
- Founded
- NBIX 1992
- APG 1926
- Country
- NBIX United States
- APG United States
- Employees
- NBIX N/A
- APG N/A
- Industry
- NBIX Biotechnology: Biological Products (No Diagnostic Substances)
- APG Engineering & Construction
- Sector
- NBIX Health Care
- APG Consumer Discretionary
- Exchange
- NBIX Nasdaq
- APG Nasdaq
- Market Cap
- NBIX 13.2B
- APG 14.6B
- IPO Year
- NBIX 1996
- APG N/A
- Fundamental
- Price
- NBIX $128.91
- APG $35.06
- Analyst Decision
- NBIX Strong Buy
- APG Strong Buy
- Analyst Count
- NBIX 22
- APG 10
- Target Price
- NBIX $165.59
- APG $36.48
- AVG Volume (30 Days)
- NBIX 935.9K
- APG 2.9M
- Earning Date
- NBIX 07-30-2025
- APG 07-31-2025
- Dividend Yield
- NBIX N/A
- APG N/A
- EPS Growth
- NBIX 2.97
- APG N/A
- EPS
- NBIX 3.39
- APG 0.34
- Revenue
- NBIX $2,509,900,000.00
- APG $7,396,000,000.00
- Revenue This Year
- NBIX $16.12
- APG $8.22
- Revenue Next Year
- NBIX $15.06
- APG $5.44
- P/E Ratio
- NBIX $38.04
- APG $102.98
- Revenue Growth
- NBIX 18.42
- APG 7.59
- 52 Week Low
- NBIX $84.23
- APG $20.50
- 52 Week High
- NBIX $157.98
- APG $36.55
- Technical
- Relative Strength Index (RSI)
- NBIX 46.34
- APG 58.13
- Support Level
- NBIX $130.75
- APG $34.28
- Resistance Level
- NBIX $137.44
- APG $36.55
- Average True Range (ATR)
- NBIX 3.60
- APG 0.68
- MACD
- NBIX -0.71
- APG -0.05
- Stochastic Oscillator
- NBIX 33.88
- APG 48.80
About NBIX Neurocrine Biosciences Inc.
Neurocrine Biosciences Inc engages in the discovery, development, and commercialization of drugs for the treatment of neurological and endocrine-related diseases and disorders in the United States. The company's products include INGREZZA for tardive dyskinesia and chorea associated with Huntington's disease; ALKINDI for adrenal insufficiency; Efmody capsules for classic congenital adrenal hyperplasia; Orilissa tablets for endometriosis; and Oriahnn capsules to treat uterine fibroids.
About APG APi Group Corporation
APi Group Corp operates in two segments: Safety Services segment includes providing safety services in North America, Asia Pacific, and Europe, focusing on end-to-end integrated occupancy systems (fire protection solutions, Heating, Ventilation, and Air Conditioning and entry systems), including design, installation, inspection, and service of these integrated systems. These services are provided in commercial, education, healthcare, high tech, industrial, and special-hazard settings. Specialty Services segment includes providing a variety of infrastructure services and specialized industrial plant services, which include maintenance and repair of critical infrastructure such as underground electric, gas, water, sewer, and telecommunications infrastructure.